Charter Renewal for the Advisory Committee on Infant and Maternal Mortality, 67767 [2023-21716]
Download as PDF
67767
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices
TABLE 1—RECIPIENTS AND SUPPLEMENT AWARD AMOUNTS
Grant No.
Award recipient name
U1IMC45814 ..................................................
U1IMC43532 ..................................................
Children’s National Medical Center ....................................................
University Hospitals Cleveland Medical Center .................................
Amount of Non-Competitive
Award(s): Two awards at $400,000 per
grant recipient totaling $800,000.
Project Period: September 1, 2023, to
August 31, 2024.
Assistance Listing (CFDA) Number:
93.110.
Award Instrument: Supplement for
RPPN support services.
Justification: Approximately $400,000
in supplemental funding has been
awarded to each RPPN cooperative
agreement recipient to increase
activities to coordinate among the
nation’s pediatric hospitals and their
communities to prepare for and respond
to global health threats and coordinate
research-informed responses to future
pandemics. Projects approved by HRSA
under this supplement are to be
performed from the date of award
through August 31, 2024.
Carole Johnson,
Administrator.
[FR Doc. 2023–21670 Filed 9–29–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Charter Renewal for the Advisory
Committee on Infant and Maternal
Mortality
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Department of Health and Human
Services is giving notice that the
Advisory Committee on Infant and
Maternal Mortality (ACIMM or
Committee) is renewed. The effective
date of the charter renewal is September
30, 2023.
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health
Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, Maryland
20857; 301–443–0543; or VLee1@
hrsa.gov.
SUPPLEMENTARY INFORMATION: ACIMM is
authorized by section 222 of the Public
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:41 Sep 29, 2023
Jkt 262001
Health Service Act (42 U.S.C. 217a), as
amended. The Committee is governed
by provisions of Public Law 92–463, as
amended (5 U.S.C. 10), which sets forth
standards for the formation and use of
Advisory Committees. ACIMM advises
the Secretary of Health and Human
Services on department activities,
partnerships, policies, and programs
directed at reducing infant mortality,
maternal mortality and severe maternal
morbidity, and improving the health
status of infants and women before,
during, and after pregnancy. The
Committee provides advice on how best
to coordinate Federal, State, local,
Tribal, and Territorial governmental
efforts designed to improve infant
mortality, related adverse birth
outcomes, and maternal health, as well
as influence similar efforts in the private
and voluntary sectors. The Committee
provides guidance and
recommendations on the policies,
programs, and resources required to
address the disparities and inequities in
infant mortality, related adverse birth
outcomes and maternal health
outcomes, including maternal mortality
and severe maternal morbidity. With its
focus on underlying causes of the
disparities and inequities seen in birth
outcomes for women and infants, the
Committee advises the Secretary of
Health and Human Services on the
health, social, economic, and
environmental factors contributing to
the inequities and proposes structural,
policy and/or systems level changes.
The charter renewal for ACIMM was
approved on September 8, 2023. The
filing date is September 30, 2023.
Renewal of the ACIMM charter gives
authorization for the committee to
operate until September 30, 2025.
A copy of the ACIMM charter is
available on the ACIMM website at
https://www.hrsa.gov/advisorycommittees/infant-mortality/.
A copy of the charter also can be
obtained by accessing the FACA
database that is maintained by the
Committee Management Secretariat
under the General Services
Administration. The website address for
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
City, state
Award amount
MD
OH
$400,000
400,000
the FACA database is https://
www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–21716 Filed 9–29–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group, Therapeutic Development and
Preclinical Studies Study Section.
Date: October 25–26, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Richard D Schneiderman,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
Bethesda, MD 20817, 301–402–3995,
richard.schneiderman@nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group, Cellular and Molecular
Technologies Study Section.
Date: October 25–26, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tatiana V Cohen, Ph.D.,
Scientific Review Officer, Center for
E:\FR\FM\02OCN1.SGM
02OCN1
Agencies
[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Page 67767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21716]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Charter Renewal for the Advisory Committee on Infant and Maternal
Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Department of Health and Human Services is giving notice that the
Advisory Committee on Infant and Maternal Mortality (ACIMM or
Committee) is renewed. The effective date of the charter renewal is
September 30, 2023.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, Maryland 20857; 301-443-0543; or [email protected].
SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of Public Law 92-463, as amended (5 U.S.C.
10), which sets forth standards for the formation and use of Advisory
Committees. ACIMM advises the Secretary of Health and Human Services on
department activities, partnerships, policies, and programs directed at
reducing infant mortality, maternal mortality and severe maternal
morbidity, and improving the health status of infants and women before,
during, and after pregnancy. The Committee provides advice on how best
to coordinate Federal, State, local, Tribal, and Territorial
governmental efforts designed to improve infant mortality, related
adverse birth outcomes, and maternal health, as well as influence
similar efforts in the private and voluntary sectors. The Committee
provides guidance and recommendations on the policies, programs, and
resources required to address the disparities and inequities in infant
mortality, related adverse birth outcomes and maternal health outcomes,
including maternal mortality and severe maternal morbidity. With its
focus on underlying causes of the disparities and inequities seen in
birth outcomes for women and infants, the Committee advises the
Secretary of Health and Human Services on the health, social, economic,
and environmental factors contributing to the inequities and proposes
structural, policy and/or systems level changes.
The charter renewal for ACIMM was approved on September 8, 2023.
The filing date is September 30, 2023. Renewal of the ACIMM charter
gives authorization for the committee to operate until September 30,
2025.
A copy of the ACIMM charter is available on the ACIMM website at
https://www.hrsa.gov/advisory-committees/infant-mortality/. A
copy of the charter also can be obtained by accessing the FACA database
that is maintained by the Committee Management Secretariat under the
General Services Administration. The website address for the FACA
database is https://www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-21716 Filed 9-29-23; 8:45 am]
BILLING CODE 4165-15-P